Cécile Arellano - Concepedia

Author

Cécile Arellano

Université Toulouse III - Paul Sabatier ORCID

Also Known As

C Arellano, C. Arellano, Cecile Arellano, Cécile Arellano

Publications

758

Citations

H-Index

Concepts

All Affiliations

Université Toulouse III - Paul Sabatier Institut Claudius Regaud Inserm Université Fédérale de Toulouse Midi-Pyrénées Centre de Recherche en Cancérologie de Toulouse

About

Cécile Arellano is an author at Université Toulouse III - Paul Sabatier specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	590
2	Biochemistry	9	9	481
3	Natural Sciences	2	2	62
4	Health Sciences	1	1	28
5	Chemistry	1	1	31

Cécile Arellano

Publications

694

Citations

H-Index

Page 1

	Year	Citations
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo Gilles Cornaire, John M. Woodley, P Hermann, International Journal of Pharmaceutics Pharmaceutical ScienceBiochemistryExcipientsMedicineGlycobiology	2004	294
Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study Florence Dalenc, Luigi Iuliano, Thomas Filleron, The Journal of Steroid Biochemistry and Molecular Biology Cancer MetabolismOxysterol MetabolitesBreast OncologyOxysterolOxytam Study	2016	55
Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method Cécile Arellano, Peggy Gandia, Thierry Lafont, Journal of Chromatography B Separation ScienceUnbound FractionN-desmethyl ImatinibMedicineBioanalysis	2012	37
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed? Peggy Gandia, Cécile Arellano, Thierry Lafont, Cancer Chemotherapy and Pharmacology Therapeutic Drug MonitoringMedicinal ChemistryBiochemistryUnbound FractionMain Active Metabolite	2012	31
The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs. Cécile Arellano, Claude Philibert, Christelle Vachoux, PubMed	2007	31
Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites Marie‐Noëlle Paludetto, Christian Bijani, Florent Puisset, Journal of Medicinal Chemistry ChemistryPharmaceutical ChemistryToxicological MechanismMetalloporphyrin-catalyzed OxidationMedicinal Chemistry	2018	31
Model‐Based Quantification of Impact of Genetic Polymorphisms and Co‐Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer Alicja Puszkiel, Cécile Arellano, Christelle Vachoux, Clinical Pharmacology & Therapeutics	2020	30
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter Guylène Lafforgue, Cécile Arellano, Christelle Vachoux, Fundamental and Clinical Pharmacology Antibiotic AdjuvantDigestive TractAbsorption KineticsAntibiotic ResistanceDrug Resistance	2008	28
Validation of a liquid chromatography–mass spectrometry method to assess the metabolism of bupropion in rat everted gut sacs Cécile Arellano, Claude Philibert, Christelle Vachoux, Journal of Chromatography B BiochemistryGastrointestinal PharmacologyBioanalysisPhysiologyGastroenterology	2005	26
Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study Alicja Puszkiel, Cécile Arellano, Christelle Vachoux, Clinical Pharmacology & Therapeutics	2019	23

Page 1